Last edition
News about "Novel Pharma "
GC Biopharma and Novel Pharma Sanfilippo Syndrome Treatment Receives FDA IND Approval
GC Biopharma and Novel Pharma has announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval.
Novel Pharma | 20/05/2024 | By Aishwarya | 483
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members